- call +1-201-465-4211
- email sales@mrinsights.biz
Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
Scope of the Report:
This report focuses on the Endometriosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market.
The worldwide market for Endometriosis Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AbbVie
Astellas Pharma
AstraZeneca
Debiopharm Group
Evotec AG
Kissei Pharmaceutical
Neurocrine Biosciences
ObsEva
Pfizer
Repros Therapeutics
Roivant Sciences GmbH
Takeda Pharmaceutical Company Limited
ValiRx
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs
Market Segment by Applications, can be divided into
Hospitals
Clinics
Research Institutes
There are 15 Chapters to deeply display the global Endometriosis Drugs market.
Chapter 1, to describe Endometriosis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Endometriosis Drugs, with sales, revenue, and price of Endometriosis Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Endometriosis Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Endometriosis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Endometriosis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Endometriosis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Hormonal Therapy
1.2.2 Add-back Medication
1.2.3 Progestogens
1.2.4 Chinese Herbs
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Institutes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Endometriosis Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Astellas Pharma
2.2.1 Business Overview
2.2.2 Endometriosis Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Astellas Pharma Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Endometriosis Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Debiopharm Group
2.4.1 Business Overview
2.4.2 Endometriosis Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Debiopharm Group Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Evotec AG
2.5.1 Business Overview
2.5.2 Endometriosis Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Evotec AG Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kissei Pharmaceutical
2.6.1 Business Overview
2.6.2 Endometriosis Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kissei Pharmaceutical Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Neurocrine Biosciences
2.7.1 Business Overview
2.7.2 Endometriosis Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Neurocrine Biosciences Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 ObsEva
2.8.1 Business Overview
2.8.2 Endometriosis Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ObsEva Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Endometriosis Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Repros Therapeutics
2.10.1 Business Overview
2.10.2 Endometriosis Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Repros Therapeutics Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Roivant Sciences GmbH
2.11.1 Business Overview
2.11.2 Endometriosis Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Roivant Sciences GmbH Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Business Overview
2.12.2 Endometriosis Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Takeda Pharmaceutical Company Limited Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 ValiRx
2.13.1 Business Overview
2.13.2 Endometriosis Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 ValiRx Endometriosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Endometriosis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Endometriosis Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Endometriosis Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Endometriosis Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Endometriosis Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Endometriosis Drugs Market Analysis by Regions
4.1 Global Endometriosis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Endometriosis Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Endometriosis Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Endometriosis Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Endometriosis Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Endometriosis Drugs Sales and Growth Rate (2013-2018)
4.5 South America Endometriosis Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Endometriosis Drugs Sales and Growth Rate (2013-2018)
5 North America Endometriosis Drugs by Countries
5.1 North America Endometriosis Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Endometriosis Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Endometriosis Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Endometriosis Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Endometriosis Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Endometriosis Drugs Sales and Growth Rate (2013-2018)
6 Europe Endometriosis Drugs by Countries
6.1 Europe Endometriosis Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Endometriosis Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Endometriosis Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Endometriosis Drugs Sales and Growth Rate (2013-2018)
6.3 UK Endometriosis Drugs Sales and Growth Rate (2013-2018)
6.4 France Endometriosis Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Endometriosis Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Endometriosis Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Endometriosis Drugs by Countries
7.1 Asia-Pacific Endometriosis Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Endometriosis Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Endometriosis Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Endometriosis Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Endometriosis Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Endometriosis Drugs Sales and Growth Rate (2013-2018)
7.5 India Endometriosis Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Endometriosis Drugs Sales and Growth Rate (2013-2018)
8 South America Endometriosis Drugs by Countries
8.1 South America Endometriosis Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Endometriosis Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Endometriosis Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Endometriosis Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Endometriosis Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Endometriosis Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Endometriosis Drugs by Countries
9.1 Middle East and Africa Endometriosis Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Endometriosis Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Endometriosis Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Endometriosis Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Endometriosis Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Endometriosis Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Endometriosis Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Endometriosis Drugs Sales and Growth Rate (2013-2018)
10 Global Endometriosis Drugs Market Segment by Type
10.1 Global Endometriosis Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Endometriosis Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Endometriosis Drugs Revenue and Market Share by Type (2013-2018)
10.2 Hormonal Therapy Sales Growth and Price
10.2.1 Global Hormonal Therapy Sales Growth (2013-2018)
10.2.2 Global Hormonal Therapy Price (2013-2018)
10.3 Add-back Medication Sales Growth and Price
10.3.1 Global Add-back Medication Sales Growth (2013-2018)
10.3.2 Global Add-back Medication Price (2013-2018)
10.4 Progestogens Sales Growth and Price
10.4.1 Global Progestogens Sales Growth (2013-2018)
10.4.2 Global Progestogens Price (2013-2018)
10.5 Chinese Herbs Sales Growth and Price
10.5.1 Global Chinese Herbs Sales Growth (2013-2018)
10.5.2 Global Chinese Herbs Price (2013-2018)
11 Global Endometriosis Drugs Market Segment by Application
11.1 Global Endometriosis Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Research Institutes Sales Growth (2013-2018)
12 Endometriosis Drugs Market Forecast (2018-2023)
12.1 Global Endometriosis Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Endometriosis Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Endometriosis Drugs Market Forecast (2018-2023)
12.2.2 Europe Endometriosis Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Endometriosis Drugs Market Forecast (2018-2023)
12.2.4 South America Endometriosis Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Endometriosis Drugs Market Forecast (2018-2023)
12.3 Endometriosis Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Endometriosis Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Endometriosis Drugs Market Share Forecast by Type (2018-2023)
12.4 Endometriosis Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Endometriosis Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Endometriosis Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Endometriosis Drugs Picture
Table Product Specifications of Endometriosis Drugs
Figure Global Sales Market Share of Endometriosis Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
